| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |